SCHEMBL9905166

SCHEMBL9905166

CSc1cccc(C(=O)N=C(NCC(C)C)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 10/20 0.36
HDAC4 P56524 10/20 0.36
HDAC1 Q13547 10/20 0.36
HDAC7 Q8WUI4 10/20 0.36
HDAC2 Q92769 10/20 0.36
HDAC10 Q969S8 10/20 0.36
HDAC11 Q96DB2 10/20 0.36
HDAC8 Q9BY41 10/20 0.36
HDAC6 Q9UBN7 10/20 0.36
HDAC9 Q9UKV0 10/20 0.36
HDAC5 Q9UQL6 10/20 0.36
NCOR2 Q9Y618 5/20 0.36
CFTR P13569 1/20 0.36
HSD17B10 Q99714 3/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
GAA P10253 2/20 0.35
ALPL P05186 2/20 0.34
CA12 O43570 1/20 0.34
RPA1 P27694 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9905160 1.00 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9905165 1.00 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558434 0.90 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558579 0.87 HDAC3 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558035 0.86 MAPT (0.46) ACRKDM4ENPC1RAB9AKMT2A
SCHEMBL18558245 0.85 VNN1 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18558558 0.85 VNN1 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18556491 0.85 CA12 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18557797 0.85 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9905140 0.85 HDAC3 (0.35) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648511-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF Lycera Corporation (US) 2013-10-16 EP disclosed
WO-2012078874-A1 PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed